| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 155.720 | 84.565 | 220 | - | - | - | - | - | - | - |
| Total Income - EUR | 157.138 | 85.125 | 221 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 172.328 | 82.189 | 6.416 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -15.191 | 2.936 | -6.195 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -15.191 | 1.207 | -6.202 | - | - | - | - | - | - | - |
| Employees | 2 | 1 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Rinmedex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.522 | 11.074 | 7.360 | - | - | - | - | - | - | - |
| Current Assets | 248.648 | 254.858 | 243.617 | - | - | - | - | - | - | - |
| Inventories | 17.493 | 21.598 | 21.014 | - | - | - | - | - | - | - |
| Receivables | 131.505 | 123.801 | 117.423 | - | - | - | - | - | - | - |
| Cash | 99.650 | 109.459 | 105.180 | - | - | - | - | - | - | - |
| Shareholders Funds | 43.046 | 43.813 | 36.870 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | - | - | - | - | - | - | - |
| Debts | 218.300 | 222.293 | 214.277 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Rinmedex S.r.l.